Home › Funds › Kynam Capital Management, LP › GERN
Kynam Capital Management, LP position in GERN
GERON CORP · Health Care
Kynam Capital Management, LP reported holding 6,836,318 shares of GERN (GERON CORP) in its Q2 2026 13F filing — a position valued at US$8.8M, representing 0.48% of its reported portfolio and ranking #24 among its reported holdings. Kynam Capital Management, LP has disclosed GERN holdings in 6 of the last 6 reported quarters, going back to Q1 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Kynam Capital Management, LP's GERN position evolved
Kynam Capital Management, LP first disclosed a stake in GERN in Q1 2025 at 3,659,526 shares (US$5.8M). The position peaked in Q1 2026 at 6,836,318 shares, worth US$10.2M. Across 6 filings, Kynam Capital Management, LP increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 3 time(s). The most recent filing (Q2 2026) shows 6,836,318 shares valued at US$8.8M. Notable position changes include a 98% increase in Q1 2026 (shares fell 14% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2025 | 3.66M | $5.82M | New |
| Q2 2025 | 3.46M | $4.87M | Reduce |
| Q3 2025 | 3.46M | $4.74M | Hold |
| Q4 2025 | 3.46M | $4.56M | Hold |
| Q1 2026 | 6.84M | $10.19M | Add |
| Q2 2026 | 6.84M | $8.75M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About GERN and 13F data
GERN (GERON CORP) is a Health Care company. 18 other funds we track also report a position in GERN — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$54.8M), Soleus Capital Management, L.P. (US$54.8M), Eversept Partners, LP (US$24.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding GERN
- RA CAPITAL MANAGEMENT, L.P. 42.81M sh · $54.80M · Q2 2026
- Soleus Capital Management, L.P. 42.81M sh · $54.80M · Q2 2026
- Eversept Partners, LP 18.72M sh · $23.96M · Q2 2026
- Nantahala Capital Management, LLC 12.22M sh · $15.65M · Q2 2026
- Vivo Capital, LLC 8.67M sh · $11.10M · Q2 2026
More on Kynam Capital Management, LP
FAQ
How long has Kynam Capital Management, LP held GERN?
Kynam Capital Management, LP has disclosed GERN holdings in 6 of the last 6 reported quarters, going back to Q1 2025.
What is Kynam Capital Management, LP's current position in GERN?
As of Q2 2026, Kynam Capital Management, LP holds 6.84M shares of GERN (GERON CORP), valued at $8.75M, representing 0.48% of its reported portfolio and ranking #24.
Has Kynam Capital Management, LP been buying or selling GERN?
In the latest 13F filing (Q2 2026), Kynam Capital Management, LP held unchanged its position in GERN. The position peaked in Q1 2026 at 6.84M shares.
Which other funds hold GERN?
Other major institutional holders of GERN include RA CAPITAL MANAGEMENT, L.P., Soleus Capital Management, L.P., Eversept Partners, LP, among 18 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.